Constantine Chinoporos
Chief Operating Officer chez APPLIED THERAPEUTICS, INC.
Fortune : 2 M $ au 31/03/2024
Postes actifs de Constantine Chinoporos
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| APPLIED THERAPEUTICS, INC. | Chief Operating Officer | 28/12/2023 | - |
Historique de carrière de Constantine Chinoporos
Anciens postes connus de Constantine Chinoporos
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ALBIREO PHARMA, INC. | Corporate Officer/Principal | 02/12/2021 | 01/03/2023 |
Boston Pharmaceuticals, Inc.
 Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Boston Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that leverages a drug development team to advance a portfolio of high value candidates that address important unmet medical needs. The company was founded by Robert Armstrong and Chris Viehbacher and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/11/2015 | 01/10/2021 |
Formation de Constantine Chinoporos
| Cornell University | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 5 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Masters Business Admin | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| APPLIED THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Boston Pharmaceuticals, Inc.
Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Boston Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that leverages a drug development team to advance a portfolio of high value candidates that address important unmet medical needs. The company was founded by Robert Armstrong and Chris Viehbacher and is headquartered in Cambridge, MA. | Commercial Services |
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA. | Health Technology |
- Bourse
- Insiders
- Constantine Chinoporos
- Expérience
